CTCheng Yu Tsai

Cheng Yu Tsai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cheng Yu Tsai has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Fu-Long Huang

    Department of Food Nutrition, Chung Hwa University of Medical Technology, Tainan, Taiwan, R.O.C.

    3 shared publications
  • Huey-Jiun Ko

    Division of Neurosurgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, R.O.C.

    3 shared publications
  • Wei-Chung Chen

    Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, R.O.C.

    3 shared publications
  • Yu-Feng Su

    Division of Neurosurgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, R.O.C.

    3 shared publications
  • Chien-Feng Li

    Department of Pathology, Chi-Mei Medical Center, Tainan 71004, Taiwan

    2 shared publications
  • Joon-Khim Loh

    Division of Neurosurgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, R.O.C.

    2 shared publications

Latest Publications

  • Gallic Acid as a Non-cytotoxic Modulator of the ROS–EGFR–ERK–EMT Axis in Xenograft-derived T98G Glioblastoma Cells

    by Yu-Feng Su, Huey-Jiun Ko, Wei-Chung Chen, Fu-Long Huang, Joon-Khim Loh, Cheng-Yu Tsai

    Glioblastoma (GBM) cells that adapt to the in vivo microenvironment often display enhanced invasion driven by EGFR-ERK signaling and epithelial-mesenchymal transition (EMT). This study aimed to characterize an EGFR-ERK-dependent T98G subline (T98G-xeno) and to determine how gallic acid (GA) modulates reactive oxygen species (ROS), EGFR-ERK signaling, EMT and migration. Parental T98G and T98G-xeno cells were compared for proliferation, EMT markers and migration. GA cytotoxicity, ROS, EGFR-ERK signaling and migration were assessed after GA, EGF, N-acetyl-L-cysteine (NAC) or EGFR siRNA treatment. T98G-xeno cells showed faster growth, increased migration, higher levels of mesenchymal markers, and elevated basal p-EGFR/p-ERK ratio versus T98G cells. Non-apoptotic GA increased ROS, decreased p-EGFR/EGFR and p-ERK/ERK ratios, restored E-cadherin/ZO-1, reduced N-cadherin/vimentin and inhibited wound closure and migration. EGF-induced EGFR-ERK activation and migration were antagonized by GA. EGFR siRNA mimicked GA, whereas NAC attenuated GA-induced ROS and partially rescued these effects. GA targets a ROS-EGFR-ERK-EMT axis in T98G-xeno cells, acting as a non-cytotoxic modulator that reverses EMT and limits migration. These findings suggest that GA-based strategies may help restrain invasion in EGFR-ERK-addicted, EMT-enriched GBM.


  • 6-Gingerol overcomes TMZ resistance in GBM by suppressing EMT and cell migration via the PI3K/Akt/β-catenin/c-Myc pathway

    by Yao-Lin Lee, Joon-Khim Loh, Huey-Jiun Ko, Wei-Chung Chen, Yu-Feng Su, Tai-Hsin Tsai, Fu-Long Huang, Chien-Feng Li, Cheng Yu Tsai


  • Open Access

    6-Gingerol Induced Apoptosis and Cell Cycle Arrest in Glioma Cells via MnSOD and ERK Phosphorylation Modulation

    by Sher-Wei Lim, Wei-Chung Chen, Huey-Jiun Ko, Yu-Feng Su, Chieh-Hsin Wu, Fu-Long Huang, Chien-Feng Li, Cheng Yu Tsai

    Sher-Wei Lim, Wei-Chung Chen, Huey-Jiun Ko, Yu-Feng Su, Chieh-Hsin Wu, Fu-Long Huang, Chien-Feng Li and Cheng Yu Tsai. Biomolecules & Therapeutics 2025;33:129-42. https://doi.org/10.4062/biomolther.2024.084


  • Open Access

    An Analysis of Emergency Surgical Outcomes for Pediatric Traumatic Brain Injury: A Ten-Year Single-Institute Retrospective Study in Taiwan

    by Cheng-Yu Tsai, Keng-Liang Kuo, Chieh-Hsin Wu, Tai-Hsin Tsai, Hui-Yuan Su, Chih-Lung Lin, Ann-Shung Lieu, Aij-Lie Kwan, Yu-Feng Su, Joon-Khim Loh

    Background and Objectives: Pediatric traumatic brain injury (pTBI) remains a major pediatric public health problem, despite well-developed injury prevention programs. The purpose of this study is to analyze the emergency surgical outcomes of pTBI in a single institute ten-year retrospective study to offer a real-world clinical result. Materials and Methods: Our institute presented a clinical retrospective, single-institute research study of 150 pediatric TBI cases that were diagnosed and underwent emergency surgical treatment from 2010 to 2019. Results: The incidence of radiological findings is detailed as follows: brain edema (30%, 45/150), followed by acute subdural hematoma (27.3%, 41/150), epidural hematoma (21.3%, 32/150), chronic subdural hemorrhage (10%, 15/150), skull fracture (6.7%, 10/150), and traumatic subarachnoid hemorrhage (4.7%, 7/150). Surgical intervention data revealed that decompressive craniectomy was still the main effective surgical method. The results showed longer hospital stays and higher morbidity rates in the brain edema, acute subdural hematoma, and chronic subdural hemorrhage groups, which were viewed as poor surgical outcome groups. Epidural hematoma, skull fracture and traumatic subarachnoid hemorrhage were categorized into good surgical outcome groups. Notably, the data revealed gross improvement in Glasgow Coma Scale/Score (GCS) evolution after surgical interventions, and the time to cranioplasty was a significant factor in the development of post-traumatic hydrocephalus (PTH). Conclusions: Our study provided real-world data for the distribution of etiology in pTBI and also categorized it into six groups, indicating disease-orientated treatment. In addition, our data supported that decompressive craniectomy (DC) remains a mainstay surgical treatment in pTBI and early cranioplasty could decrease the incidence of PTH.